Drug Development 2019

28 March 2019 - 29 March 2019
New South Wales, Australia
Venue - Garvan Institute Auditorium, Basement Level, 384 Victoria st, Sydney

 

Annual early phase cancer meeting is on again in March 28-29, 2019. Registration is free for academics on the website and there is a great lineup of speakers this year including:

 

Prof David Bowtell (Genomics, Ovarian cancer) - Peter Maccallum Cancer Centre
Prof Sarah Blagden (PI3K pathway, Ovarian cancer) – University of Oxford

Prof Felix Feng (Genomics, Radiation response, Prostate cancer) - UCSF

Prof Anant Madabushi (Radiomics, Histomorphometrics as biomarkers) – Case Western

Dr Peter Eu - Science of Radiopharmaceuticals 

Early phase trials with radiopharmacetuicals – Shahneen Sandhu

 

Please join us, will be a great opportunity to collaborate with clinical , and industry colleagues!